Company name: DAIICHI SANKYO COMPANY, LIMITED Representative: Joji Nakayama, Representative Director, President and CEO (Code no.: 4568, First Section, Tokyo Stock Exchange) Please address inquiries to Noriaki Ishida, Corporate Officer, Vice ... Noodls, 1 hour ago
DAIICHI SANKYO : Correction to the release titled "Ranbaxy Q1 FY 2015(Apr'14-Jun'14) Sales Rs.23.7 Bn" - 4 Traders, 7 hours ago
Ranbaxy Laboratories : DAIICHI-SANKYO -Ranbaxy Q1 FY 2015 (Apr'14-Jun'14) Sales Rs.23.7 Bn Growth registered in Base business profitability - 4 Traders, 1 day ago
Sun Pharma agreed to buy Ranbaxy for $3.2 billion in stock from its Japanese parent Daiichi Sankyo Co. Ltd. It also agreed to take on $800 million of Ranbaxy's debt. Photo: Hemant Mishra/Mint New Delhi: Sun Pharmaceutical Industries Ltd 's ...Livemint.com, 1 day ago Ranbaxy is now Daiichi's Pune Mirror, 2 weeks ago Indian bourses' nod for Sun Pharma-Ranbaxy deal Rediff.com, 1 week ago Sun Pharma-Ranbaxy deal gets no-objection from BSE, NSE Hindu Business Line, 1 week ago
Daiichi Sankyo, owner of Ranbaxy Laboratories Limited, has filed a petition in Andhra Pradesh High Court requesting it to vacate the 'status quo' order it issued earlier on Sun Pharma-Ranbaxy merger process.Money Control, 2 months ago Daiichi files plea in HC to vacate stay on Sun-Ranbaxy merger Business Standard, 2 months ago Daiichi files plea in HC on Sun-Ranbaxy merger Times of India, 2 months ago
More from: Sify, Rediff.com...and 1 other sources
Daiichi Sankyo and Eli Lilly and Company: Heart patients in England and Wales offered more choice of therapies as NICE extends recommendations for prasugrel
GERRARDS CROSS, England--(BUSINESS WIRE)--Jul. 23, 2014-- Revised guidance from the National Institute for Health and Care Excellence (NICE), recommends once-daily, oral antiplatelet prasugrel (Efient), in combination with aspirin, as a ...BusinessWeek, 1 week ago Cost watchdog expands NHS use of bloodthinner Efient Big News Network, 1 week ago Daiichi Sankyo, Inc. And Eli Lilly and Company: Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel BioSpace, 1 week ago Court Report -- Part II - July 2014 #2 JD Supra, 16 hours ago
Mitsubishi Tanabe Pharma Corporation and Daiichi Sankyo Co., Ltd. have announced that Mitsubishi has received approval to manufacture and market the SGLT2 inhibitor, CANAGLU tablets 100mg in Japan, for the treatment of patients with type 2 diabetes ...Individual.com, 2 weeks ago DAIICHI SANKYO -Marketing and Manufacturing Approval in Japan Received for CANAGLU Tablets 100mg TMC Net, 3 weeks ago Japan marketing approval for Canaglu; Vaccine license for Daiichi Sankyo Pharma Letter, 3 weeks ago Marketing and Manufacturing Approval in Japan Received for CANAGLU® Tablets 100mg Noodls, 3 weeks ago
USA-based Portola Pharmaceuticals (Nasdaq: PTLA) has entered into a second clinical collaboration agreement with Japanese drug major Daiichi Sankyo (TYO: 4568) to study andexanet alfa, Portola's investigational Factor Xa inhibitor antidote, in Phase ...Pharma Letter, 2 weeks ago Portola, Daiichi Expand Clinical Collaboration Contract Pharma, 3 weeks ago Portola inks collaboration deal with Daiichi Sankyo Seeking Alpha, 3 weeks ago Portola, Daiichi Sankyo collaborate for Phase III studies of factor Xa inhibitor antidote Pharmaceutical Business Review, 3 weeks ago
DAIICHI SANKYO -Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) 'Squarekids subcutaneous injection syringe'
[July 08, 2014] (ENP Newswire Via Acquire Media NewsEdge) ENP Newswire - 08 July 2014 Release date- 04072014 - Tokyo, Japan - Daiichi Sankyo Co., Ltd. (hereinafter Daiichi Sankyo) and Sanofi K.K. announce that Kitasato Daiichi ...TMC Net, 3 weeks ago DAIICHI SANKYO : Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) 'Squarekids subcutaneous injection syringe' 4 Traders, 3 weeks ago Announcement on obtaining in Japan the marketing and manufacturing license for the 4-valent combination vaccine for the prevention of Pertussis, Diphtheria, Tetanus and Poliomyelitis (Polio) Squarekids® subcutaneous injection syringe Noodls, 3 weeks ago
More from: , PipelineReview...and 1 other sources
American Regent's Injectafer® (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States
American Regent, Inc., a subsidiary of Luitpold Pharmaceuticals, Inc. (a Daiichi Sankyo Group Company), announced today the double-digit sales growth of Injectafer ® (ferric carboxymaltose injection) in 2014, making it the ...Town Hall, 2 weeks ago American Regent Reports Sales Growth of Injectafer Pharmaceutical & Medical Packaging News, 1 week ago American Regent's Injectafer (Ferric Carboxymaltose Injection) Now the Fastest Growing IV Iron in United States Pharmacy Choice, 2 weeks ago American Regent's Injectafer(r) (Ferric Carboxymaltose Injection) N... Finwin, 2 weeks ago
More from: BioSpace, Stock Nod...and 31 other sources
DAIICHI SANKYO : New Acinetobacter baumannii Study Findings Recently Were Reported by Researchers at Daiichi Sankyo (Anti-multidrug-resistant Acinetobacter baumannii...
New Acinetobacter baumannii Study Findings Recently Were Reported by Researchers at Daiichi Sankyo (Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection ...) ...4 Traders, 9 hours ago DAIICHI SANKYO : Reports on Hypoglycemia Findings from Daiichi Sankyo Provide New Insights (Discovery of 3-aryl-3-ethoxypropanoic acids as orally active GPR40... 4 Traders, 3 weeks ago Sanford-Burnham Medical Research Institute ClinicSpace, 3 weeks ago
LONDON—MRC Technology and have begun a drug discovery collaboration focused on identifying and selecting novel drug targets that could potentially become potent and selective therapeutics for the treatment of diseases such as oncology, ...Drug Discovery News, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!